
Sign up to save your podcasts
Or


Allergies seem impromptu but also predictable. They come back with the changing seasons when the immune system interprets spring, summer, or fall in protective but hyperbolic ways. To manage allergies, particularly pollen allergies, humans have used steam bowls, neti pots, acupuncture, first-generation antihistamines (effective, but sleep inducing), second-generation antihistamines (non-drowsy), and, more recently, a new catalog of sprays for treating sinuses and itching. These changes are chronicled in the episode. In addition, we look at several decisions that happened between 1997 and the 2020s, including FDA's decision to allow DTC in 1997 and eventually their decision to permit Claritin, Zyrtec, and Allegra to move from the prescription pad to the counter.
Health literacy is our guiding principle: with such knowledge, you may understand the label without on any prescription and select one that offers relief, provided the mechanism and symptom are clearly matched. This is decision-making and design, not deregulation. Breathe deeply a few times, select what's most suitable, and proceed.
Notes:
This episode makes limited use of archival audio, advertisements, or public statements for purposes of commentary, critique, and scholarship. These uses fall under the doctrine of fair use as defined by U.S. copyright law (17 U.S.C. § 107). All excerpts are employed selectively and transformatively to support critical analysis, educational inquiry, and public understanding. No commercial gain is derived from their inclusion.
By William Hoffman, Ph.D.Allergies seem impromptu but also predictable. They come back with the changing seasons when the immune system interprets spring, summer, or fall in protective but hyperbolic ways. To manage allergies, particularly pollen allergies, humans have used steam bowls, neti pots, acupuncture, first-generation antihistamines (effective, but sleep inducing), second-generation antihistamines (non-drowsy), and, more recently, a new catalog of sprays for treating sinuses and itching. These changes are chronicled in the episode. In addition, we look at several decisions that happened between 1997 and the 2020s, including FDA's decision to allow DTC in 1997 and eventually their decision to permit Claritin, Zyrtec, and Allegra to move from the prescription pad to the counter.
Health literacy is our guiding principle: with such knowledge, you may understand the label without on any prescription and select one that offers relief, provided the mechanism and symptom are clearly matched. This is decision-making and design, not deregulation. Breathe deeply a few times, select what's most suitable, and proceed.
Notes:
This episode makes limited use of archival audio, advertisements, or public statements for purposes of commentary, critique, and scholarship. These uses fall under the doctrine of fair use as defined by U.S. copyright law (17 U.S.C. § 107). All excerpts are employed selectively and transformatively to support critical analysis, educational inquiry, and public understanding. No commercial gain is derived from their inclusion.